TDEs establish immunosuppressive conditions by transporting molecules like PD-L1, TGF-β, and miR-1246, reprogramming immune cells into tumor-supportive phenotypes such as TAMs, Tregs, and MDSCs. This evidence concerns the gene CD274 and neoplasm.